ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A. (“Company” or “Alliança”) (B3: AALR3), in accordance with the provisions of art. 157, 4th paragraph of Law No. 6,404 of December 15, 1976, as amended, and in CVM Resolution No. 44, of August 23, 2021, as amended, hereby informs its shareholders and the market in general that the composition of the Company’s Board of Directors and Executive Board has been changed, as resolved at the Extraordinary and Ordinary General Meeting held on April 29, 2025 at 11:30 a.m., and at the Board of Directors Meeting held on April 29, 2025 at 5:30 p.m., respectively.
The change in the Company’s management is aligned with the Strategic Plan for Continuous Efficiency and Growth and aims to make the Corporate Governance structure more efficient and agile.
With a term of office until the Ordinary General Meeting for approval of the management accounts for the fiscal year 2026, the Company’s Board of Directors will be composed of (a) Isabella de Queiroz Sequeiros Tanure Correa – Chairman of the Board; (b) Pedro de Moraes Borba – Vice Chairman; (c) Pedro Grossi Júnior – Independent Board Member; (d) Marcos del Corona Marcos – Independent Director; and (e) Karla Maciel Dolabella – Director.
The Company’s Board of Directors is now composed of (a) Ricardo de Magalhães Sartim – Chief Executive Officer; (b) Pedro Capobianco Gibbon – Chief Financial and Investor Relations Officer; (c) José Luiz Mendes Ramos Júnior – Chief Legal and Compliance Officer. All of them will serve until the Annual General Meeting to approve the management accounts for the fiscal year 2026.
Finally, we would like to thank the previous directors for their dedication and diligence during the period in which they held their positions and functions at the Company.
São Paulo, April 29th , 2025
ALLIANÇA SAÚDE PARTICIPAÇÕES S.A.